Emma Aarnio

452 total citations
34 papers, 286 citations indexed

About

Emma Aarnio is a scholar working on Family Practice, Economics and Econometrics and Surgery. According to data from OpenAlex, Emma Aarnio has authored 34 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Family Practice, 15 papers in Economics and Econometrics and 13 papers in Surgery. Recurrent topics in Emma Aarnio's work include Medication Adherence and Compliance (16 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Peripheral Artery Disease Management (10 papers). Emma Aarnio is often cited by papers focused on Medication Adherence and Compliance (16 papers), Health Systems, Economic Evaluations, Quality of Life (13 papers) and Peripheral Artery Disease Management (10 papers). Emma Aarnio collaborates with scholars based in Finland, Slovakia and Indonesia. Emma Aarnio's co-authors include Janne Martikainen, Maarit Jaana Korhonen, Risto Huupponen, Jari Arokoski, Soili Törmälehto, Piia Lavikainen, Mika E. Mononen, Rami K. Korhonen, Aaron N. Winn and Jussi Vahtera and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Atherosclerosis.

In The Last Decade

Emma Aarnio

30 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma Aarnio Finland 11 107 91 89 51 35 34 286
R Levin United States 7 88 0.8× 75 0.8× 160 1.8× 159 3.1× 57 1.6× 11 444
B. Daniel Lucas United States 11 92 0.9× 56 0.6× 60 0.7× 139 2.7× 7 0.2× 28 373
Patrick Thiebaud United States 11 109 1.0× 201 2.2× 205 2.3× 136 2.7× 10 0.3× 14 649
Julio Lopez United States 7 60 0.6× 62 0.7× 98 1.1× 95 1.9× 4 0.1× 14 263
Ronald D. Scott United States 12 189 1.8× 165 1.8× 148 1.7× 204 4.0× 9 0.3× 24 550
Aarti A. Patel United States 12 51 0.5× 77 0.8× 17 0.2× 186 3.6× 12 0.3× 40 411
Regina Dalmau Spain 9 51 0.5× 51 0.6× 37 0.4× 149 2.9× 12 0.3× 36 272
Eva Lesén Sweden 12 55 0.5× 62 0.7× 39 0.4× 95 1.9× 3 0.1× 43 356
Yu. V. Lukina Russia 11 66 0.6× 83 0.9× 133 1.5× 207 4.1× 3 0.1× 115 447
Erietta Polychronopoulou Switzerland 8 88 0.8× 11 0.1× 34 0.4× 122 2.4× 10 0.3× 20 238

Countries citing papers authored by Emma Aarnio

Since Specialization
Citations

This map shows the geographic impact of Emma Aarnio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Aarnio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Aarnio more than expected).

Fields of papers citing papers by Emma Aarnio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Aarnio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Aarnio. The network helps show where Emma Aarnio may publish in the future.

Co-authorship network of co-authors of Emma Aarnio

This figure shows the co-authorship network connecting the top 25 collaborators of Emma Aarnio. A scholar is included among the top collaborators of Emma Aarnio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma Aarnio. Emma Aarnio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aarnio, Emma, et al.. (2025). Medication-related burden variation across chronic conditions: a population-based cross-sectional survey. BMC Health Services Research. 25(1). 1283–1283.
3.
Kamusheva, Maria, Emma Aarnio, Gaye Hafez, et al.. (2024). Pan‐European survey on medication adherence management by healthcare professionals. British Journal of Clinical Pharmacology. 90(12). 3135–3145. 7 indexed citations
4.
Wawruch, Martin, et al.. (2024). Non-persistence with multiple secondary prevention medications for peripheral arterial disease among older hypertensive patients. Frontiers in Pharmacology. 15. 1464689–1464689. 2 indexed citations
5.
Aarnio, Emma, et al.. (2024). Register‐based study on prescription renewal without the prescriber meeting the patient. Basic & Clinical Pharmacology & Toxicology. 135(3). 321–333.
7.
Saastamoinen, Leena, et al.. (2023). Implementation of pharmacotherapy monitoring: Experiences and views of medicine users. SHILAP Revista de lepidopterología. 12. 100377–100377. 1 indexed citations
8.
Aarnio, Emma, Risto Huupponen, Janne Martikainen, & Maarit Jaana Korhonen. (2023). Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study. SHILAP Revista de lepidopterología. 11. 100284–100284. 1 indexed citations
9.
Kardas, Przemysław, Emma Aarnio, Tamás Ágh, et al.. (2023). New terminology of medication adherence enabling and supporting activities: ENABLE terminology. Frontiers in Pharmacology. 14. 1254291–1254291. 7 indexed citations
11.
Ágh, Tamás, Maja Ortner Hadžiabdić, Kristina Garuolienė, et al.. (2022). Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study. Frontiers in Pharmacology. 13. 892240–892240. 12 indexed citations
12.
Martikainen, Janne, Emma Aarnio, Reija Männikkö, et al.. (2021). Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study. JMIR Diabetes. 6(3). e21356–e21356. 8 indexed citations
13.
Aarnio, Emma, Piia Lavikainen, Jaana Lindström, et al.. (2021). Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis. BMC Health Services Research. 21(1). 916–916. 5 indexed citations
14.
Wawruch, Martin, et al.. (2020). Factors Associated with Reinitiation of Statin Treatment in Older Patients with Peripheral Arterial Disease. Drugs & Aging. 37(8). 595–604. 1 indexed citations
15.
16.
Wawruch, Martin, Gejza Wimmer, Ján Murín, et al.. (2019). Patient-Associated Characteristics Influencing the Risk for Non-Persistence with Statins in Older Patients with Peripheral Arterial Disease. Drugs & Aging. 36(9). 863–873. 14 indexed citations
17.
Aarnio, Emma, Risto Huupponen, Jaana E. Martikainen, & Maarit Jaana Korhonen. (2019). First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology research. Research in Social and Administrative Pharmacy. 16(4). 553–559. 10 indexed citations
18.
Timonen, Johanna, et al.. (2019). The effects of reimbursement reform of antidiabetic medicines from the patients’ perspective – a survey among patients with type 2 diabetes in Finland. BMC Health Services Research. 19(1). 769–769. 9 indexed citations
19.
Aarnio, Emma, Maarit Jaana Korhonen, Risto Huupponen, & Janne Martikainen. (2015). Cost-effectiveness of statin treatment for primary prevention in conditions of real-world adherence – Estimates from the Finnish prescription register. Atherosclerosis. 239(1). 240–247. 17 indexed citations
20.
Aarnio, Emma, Janne Martikainen, Arja Helin‐Salmivaara, et al.. (2013). Register-based predictors of adherence among new statin users in Finland. Journal of clinical lipidology. 8(1). 117–125. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026